New research published in the October issue of the Journal of the American Medical Association (JAMA) suggests that patients with sepsis and septic lung injury could have a better chance of survival and recover more quickly when treated with vitamin C infusions.
There is growing interest in the use of vitamin C to treat sepsis. A life-threatening condition, sepsis occurs when an infection gets out of control and triggers an overwhelming immune response. This can potentially lead to organ failure, amputations, and death. Responsible for the deaths of more than 250,000 people in the United States and up to 8 million globally each year, sepsis is the leading cause of death among hospitalized patients and a major challenge to hospital intensive care units.
In recent years an approach using a synergistic combination of vitamin C, vitamin B1, and the hormone hydrocortisone has been showing particularly remarkable results. Developed by Dr. Paul Marik, an intensive-care physician at the Eastern Virginia Medical School in Norfolk, Virginia, in the United States, the treatment involves giving the vitamins and hormone intravenously. In a study published in the journal Chest in 2017, Marik and his colleagues describe how their approach resulted in just 4 deaths among the 47 patients who received it. An inspiring video featuring some of the team’s nurses recounts how the treatment has proved so effective that dying patients improve within 12 hours and go on to make full recoveries.
To learn more about Dr. Paul Marik’s approach to treating sepsis, see this interview with him on our website.